avibatam/meropenem (TQD3606)
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 10, 2026
To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency
(clinicaltrials.gov)
- P1 | N=32 | Completed | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Not yet recruiting ➔ Completed | Trial completion date: Nov 2025 ➔ May 2025
Trial completion • Trial completion date • Infectious Disease • Nephrology • Renal Disease
November 04, 2024
To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Infectious Disease • Nephrology • Renal Disease
April 22, 2022
To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects
(clinicaltrials.gov)
- P1 | N=56 | Not yet recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Infectious Disease
1 to 3
Of
3
Go to page
1